OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Trastuzumab deruxtecan in breast cancer
Miguel Martín, Atanasio Pandiella, Emilio Vargas, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104355-104355
Open Access | Times Cited: 14
Miguel Martín, Atanasio Pandiella, Emilio Vargas, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104355-104355
Open Access | Times Cited: 14
Showing 14 citing articles:
A mini-overview of antibody-drug conjugates in platinum-resistant ovarian cancer: A preclinical and clinical perspective
Yuxi Zhao, Hua Yuan, Ning Li, et al.
International Journal of Biological Macromolecules (2025), pp. 140767-140767
Closed Access
Yuxi Zhao, Hua Yuan, Ning Li, et al.
International Journal of Biological Macromolecules (2025), pp. 140767-140767
Closed Access
Antibody-Drug conjugates In elderly patients With Breast Cancer
Marta Bonotto, G Pieri, Rocco Esposto, et al.
The Breast (2025) Vol. 80, pp. 104428-104428
Open Access
Marta Bonotto, G Pieri, Rocco Esposto, et al.
The Breast (2025) Vol. 80, pp. 104428-104428
Open Access
Common Drug-Drug and Drug-Food Interactions in Antineoplastic Agents: A short update review
Sonia Sanajou, Terken Baydar
Hacettepe University Journal of the Faculty of Pharmacy (2025) Vol. 45, Iss. 1, pp. 92-105
Closed Access
Sonia Sanajou, Terken Baydar
Hacettepe University Journal of the Faculty of Pharmacy (2025) Vol. 45, Iss. 1, pp. 92-105
Closed Access
HER2-positive gastric cancer: from targeted therapy to CAR-T cell therapy
Qiang Shao, Junge Deng, Haoran Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Qiang Shao, Junge Deng, Haoran Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Post-Progression treatment options after CDK4/6 inhibitors in hormone Receptor-Positive HER2-Negative metastatic breast cancer
Taha Koray Şahin, Alessandro Rizzo, Deniz Can Güven, et al.
Cancer Treatment Reviews (2025), pp. 102924-102924
Closed Access
Taha Koray Şahin, Alessandro Rizzo, Deniz Can Güven, et al.
Cancer Treatment Reviews (2025), pp. 102924-102924
Closed Access
Trastuzumab Deruxtecan (T-Dxd) in Metastatic Breast Cancer with Different Her2 Expression Levels: A Real-World Effectiveness and Safety Study
Lan Xu, Qinglin Zhang, Ziwen Zhang, et al.
(2025)
Closed Access
Lan Xu, Qinglin Zhang, Ziwen Zhang, et al.
(2025)
Closed Access
Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapy
Semir Vranić, Zoran Gatalica
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 4, pp. 673-675
Open Access | Times Cited: 1
Semir Vranić, Zoran Gatalica
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 4, pp. 673-675
Open Access | Times Cited: 1
Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancer
Peipei Xie, Xiaoli Zhang, Tianyi Liu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Peipei Xie, Xiaoli Zhang, Tianyi Liu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer
S. Wu, Junnan Xu, Yiwen Ma, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
S. Wu, Junnan Xu, Yiwen Ma, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract Cancer
Shaun Alexander, Umair Aleem, Timothy W. Jacobs, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3345-3345
Open Access
Shaun Alexander, Umair Aleem, Timothy W. Jacobs, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3345-3345
Open Access
Treatment Strategies and Sequencing After Endocrine Therapy Plus CDK4/6 Inhibitors in Patients with ER+/HER2- Advanced/Metastatic Breast Cancer
Nicola Humphry
EMJ Oncology (2024), pp. 27-38
Open Access
Nicola Humphry
EMJ Oncology (2024), pp. 27-38
Open Access
(Immunopharmacology) antibody-drug conjugate
Hongmei Zheng, Yalong Yang, Yuhang Song, et al.
Elsevier eBooks (2024)
Closed Access
Hongmei Zheng, Yalong Yang, Yuhang Song, et al.
Elsevier eBooks (2024)
Closed Access
Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review
Gennaro Gadaleta‐Caldarola, Laura Lanotte, Anna Santoro, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4082-4082
Open Access
Gennaro Gadaleta‐Caldarola, Laura Lanotte, Anna Santoro, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4082-4082
Open Access
Strategies for the treatment of hormone receptor-positive HER2-low breast cancer based on clinical practice: a round table discussion
Xiang Huang, Yijia Hua, Chunxiao Sun, et al.
Translational Breast Cancer Research (2024) Vol. 5, pp. 30-30
Closed Access
Xiang Huang, Yijia Hua, Chunxiao Sun, et al.
Translational Breast Cancer Research (2024) Vol. 5, pp. 30-30
Closed Access
